Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The administration of rituximab (RTX) in vivo results in B-cell depletion, but evidence for multiple mechanisms of action have been reported. Surprisingly, B cell depletion produced a response in patients with polymyositis, which is characterized as a T cell-mediated autoimmune disorder with biopsy findings similar to Miyoshi myopathy (MM). Indeed,...
Alternative Titles
Full title
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d74f0867cea7416aba7438806326a5b7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d74f0867cea7416aba7438806326a5b7
Other Identifiers
ISSN
1471-2474
E-ISSN
1471-2474
DOI
10.1186/1471-2474-11-157
